AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Lusix lost $65 million as lab-grown diamond prices plummeted
2
Intel ends car leasing program in latest cost-cut
3
Israel urged to dump ‘Hasbara’, instead pivoting to highlight its place in the world
4
Intel shutting down startup accelerator Ignite amid massive cuts
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news

aMoon

20 stories about aMoon
Yaron Daniely

Seizing the HealthTech opportunity: Early-stage innovation takes center stage

29.04.24|Dr. Yaron Daniely
"As investment activity fluctuates and new challenges emerge, investors find themselves at a critical juncture," writes Dr. Yaron Daniely, General Partner at aMoon Fund 
רפואה עתידנות ביג דאטה דיגיטל

Israeli healthtech startups raised $2.8 billion in 2022, but tech crisis threatens growth

17.04.23|CTech
While healthtech is not immune to the overall macroeconomic environment, it proved to be more resilient in 2022, with capital raised in the sector declining by just 13% compared to other high-tech sectors which experienced a collective decline of 43%
Brachie Sprung Chief Communications Officer and Head of IR at Amoon

“I once got asked who is home with my kids, it’s an offensive question a man would never be asked”

15.02.23|Noa Gadot
Brachie Sprung, Chief Communications Officer & Head of IR at healthtech and life sciences investment fund aMoon, has always been the underdog, but that only made her more hungry for success
וועידת הרי - פאנל כיצד המשקיעים רואים את עתיד הרפואה

"When we look at investment, it is first and foremost a money decision. But we also look to make the world a better place"

11.12.22|James Spiro
A panel of physicians and VCs gathered during The Future Health Matrix in Tel Aviv held by the Israel Medical Association (IMA) to discuss investment opportunities in the future of medicine
aMoon Partners

“Global spend on healthcare is, by and large, recession-proof”

11.12.22|Elihay Vidal, James Spiro
aMoon Velocity’s Roy Wiesner and Yaniv Sadka joined CTech to share some predictions for the year ahead.
יאיר שינדל תומר ברקוביץ טוד סון גור רושוואלב שותפים ב קרן aMoon Growth

Life sciences VC aMoon raises $340 million for second fund

20.07.22|Meir Orbach
aMoon Growth II will focus on later-stage investments and will support entrepreneurs and scientists developing solutions combining biology with AI, Big Data, and other advanced technologies
מימין מריוס נכט ו יאיר שינדל

aMoon raising new massive healthtech fund

21.10.21|Meir Orbach
The Israeli life sciences VC didn't reveal the magnitude of the new fund, but it is expected to be in the region of its previous $750 million fund
מייסדים Heloes Health

Eleos Health raises $6 million Seed funding to accelerate clinicians' decision-making

13.09.21|CTech
The Israeli startup’s AI-powered Speech-to-Insights system for clinicians aims to provide more accessible, efficient, personalized and time and cost-effective care
קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Israel’s aMoon fund saw a 15-fold return on its investment in Seer

09.12.20|Sophie Shulman
aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion
ד"ר יאיר שינדל Yair schindel Gateways Stampa

Yair Schindel: aMoon’s healthtech anchor

30.11.20|CTech
Schindel’s aMoon fund has invested in 38 tech companies in Israel, the U.S. and recenly in Europe too
קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Israel’s aMoon leads $110 million funding round in SOPHiA GENETICS

04.10.20|Hagar Ravet
The new funding aims to boost the medtech company’s penetration in both the U.S. and Asian markets
ד"ר יאיר שינדל מוסף שבועי 13.2.20

Israel’s aMoon leads funding rounds in U.S. and European companies

10.09.20|Hagar Ravet
The healthtech VC led a $35 million round in MOBILion and a $30 million round in MiNA Therapeutics
מימין מריוס נכט ו יאיר שינדל

Roche, aMoon to launch early-stage innovation program

10.08.20|Hagar Ravet
The program is scheduled to run for the next three years, with three companies set to be selected and receive investments each year
צ'ק פוינט צ'קפוינט לוגו מטה החברה

Which fund topped out at $750 million and how much money did Check Point make?

22.07.20|CTech
CTech Daily Roundup: Covid-19 and no flights mean more money for Check Point as Q2 profits soar
Nectin and aMoon teams

Israeli healthtech VC aMoon Velocity invests $6 million in Nectin Therapeutics

15.07.20|James Spiro
Nectin Therapeutics places antibodies in proteins known to cause cancer, improving immune systems and blocking certain checkpoints
מריוס נכט

Nacht’s aMoon raising new fund to invest in early stage companies

22.06.20|Hagar Ravet
Velocity Fund has already invested in NanoGhosts, Vocalis Health, and IBEX
ד"ר יאיר שינדל מוסף שבועי 13.2.20

Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

21.02.20| Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
מרסל מחלוף

Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company

24.12.19|Hagar Ravet
NanoGhosts turns stem cells into a drug delivery system that specifically targets cancerous tumors
מריוס נכט 2

Marius Nacht’s aMoon Leads $55 Million Round in Healthtech Company Seer

17.12.19|Hagar Ravet
Seer develops technology for extracting molecular insights from cell proteome, to assist in the early detection of cancer and neurological diseases
Vocalis טל ונדרוב ביונד ורבל רואי ויזנר אמון דניאל אהרונוביץ ו שאדי חסן הלת'ימייז

Newly Merged Voice Analysis Startups Healthymize and Beyond Verbal Raise $9 Million

10.12.19|Hagar Ravet
The new entity, Vocalis Health, will develop technology for the voice-based analysis and detection of health issues such as heart and respiratory conditions and depression
More Articles